Daniel C. Flynn

Protea Biosciences, Inc. develops technology for micro fluidic protein separation and detection. The firm develops new technology for the identification, characterization, and quantization of biologically-important molecules for basic research, pharmaceutical development, and diagnostic applications. the company was founded by Steve Turner in 2001 and is headquartered in Morgantown, WV.

SRKP 5, Inc. was incorporated in the State of Delaware on May 24, 2005. Since inception, the company has been engaged in organizational efforts and obtaining initial financing. The firm was formed as a vehicle to pursue a business combination through the acquisition of, or merger with, an operating business. The firm, based on proposed business activities, is a 'blank check' company. It was organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly held corporation. The company will not restrict its potential candidate target companies to any specific business, industry or geographical location and, thus, may acquire any type of business.

Protea Biosciences Group, Inc. engaged in the provision of molecular information services. It offers direct analysis, mapping, and display of biologically active molecules in living cells and tissue samples through its platform technology. The company was founded by Stephen C. Turner in July 2001 and was headquartered in Morgantown, WV.

Southeastern Universities Research Association, Inc. (SURA) operates as an association of colleges and universities. It is the consortium of universities and colleges in the southern and eastern United States. It sponsors research projects in engineering, biology, physical and natural sciences. The company was founded in 1980 and is headquartered in Washington, DC.